Keros Therapeutics, Inc. (KROS)
9.36
-0.09
(-0.95%)
USD |
NASDAQ |
Nov 06, 16:00
9.315
-0.04
(-0.48%)
After-Hours: 20:00
Keros Therapeutics Total Assets (Quarterly) : 287.60M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 287.60M |
| March 31, 2026 | 312.29M |
| December 31, 2025 | 342.87M |
| September 30, 2025 | 742.78M |
| June 30, 2025 | 757.16M |
| March 31, 2025 | 784.56M |
| December 31, 2024 | 615.89M |
| September 30, 2024 | 579.27M |
| June 30, 2024 | 455.02M |
| March 31, 2024 | 485.82M |
| December 31, 2023 | 370.02M |
| September 30, 2023 | 326.25M |
| June 30, 2023 | 356.31M |
| March 31, 2023 | 384.44M |
| Date | Value |
|---|---|
| December 31, 2022 | 306.78M |
| September 30, 2022 | 252.55M |
| June 30, 2022 | 226.66M |
| March 31, 2022 | 235.14M |
| December 31, 2021 | 255.25M |
| September 30, 2021 | 229.96M |
| June 30, 2021 | 243.46M |
| March 31, 2021 | 257.73M |
| December 31, 2020 | 269.44M |
| September 30, 2020 | 138.25M |
| June 30, 2020 | 150.44M |
| March 31, 2020 | 60.59M |
| December 31, 2019 | 10.96M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agios Pharmaceuticals, Inc. | -- |
| Viking Therapeutics, Inc. | 977.17M |
| Protagonist Therapeutics, Inc. | 885.54M |
| ACADIA Pharmaceuticals, Inc. | 1.794B |
| Alnylam Pharmaceuticals, Inc. | 7.995B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 25.28M |
| Shareholders Equity (Quarterly) | 262.32M |
| Debt to Equity Ratio | 0.0599 |
| Current Ratio | 21.96 |
| Net Debt Paydown Yield | 0.25% |